Treatment for Hypertriglyceridemia
Links shared publicly online about this topic
Phase 3 study of Epanova for the treatment of hypertriglyceridemia - ONA
oncologynurseadvisor.com — “Omthera has announced it has reached an agreement with the FDA on a Special Protocol Assessment (SPA) for the design of its planned Phase 3 registration clinical trial of Epanova (eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA)) for the treatment of hypertriglyceridemia.” View full resource at oncologynurseadvisor.com
Most Recently Shared on November 23, 2010 at 7:07 pm By:
Phase 3 study of Epanova for the treatment of hypertriglyceridemia http://goo.gl/fb/In6Ci
Phase 3 study of AMR101 for the treatment of hypertriglyceridemia - ONA
oncologynurseadvisor.com — “Amarin announced positive results from its Phase 3 study of AMR101 for the treatment of very high triglyceride levels or hypertriglyceridemia.” View full resource at oncologynurseadvisor.com
Most Recently Shared on November 30, 2010 at 10:02 pm By:
Phase 3 study of AMR101 for the treatment of hypertriglyceridemia http://goo.gl/fb/whFAE
Phase 3 study of Epanova for the treatment of hypertriglyceridemia - MPR
empr.com — “Omthera has announced it has reached an agreement with the FDA on a Special Protocol Assessment (SPA) for the design of its planned Phase 3 registration clinical trial of Epanova (eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA)) for the treatment of hypertriglyceridemia.” View full resource at empr.com
Most Recently Shared on November 23, 2010 at 7:17 pm By:
MPR News: Phase 3 study of Epanova for the treatment of hypertriglyceridemia: Omthera has announced it has reach... http://bit.ly/iiS4B9
Phase 3 study of AMR101 for the treatment of hypertriglyceridemia - MPR
empr.com — “Amarin announced positive results from its Phase 3 study of AMR101 for the treatment of very high triglyceride levels or hypertriglyceridemia.” View full resource at empr.com
Most Recently Shared on November 30, 2010 at 10:44 pm By:
MPR News: Phase 3 study of AMR101 for the treatment of hypertriglyceridemia: Amarin announced positive results f... http://bit.ly/hrC6MV
Top-line Results of the Pivotal Phase 3 Clinical Trial of TAK-085 in Japan for Treatment of Hypertriglyceridemia - Drugs.com MedNews
drugs.com — “- Takeda Pharmaceutical Company Limited (Osaka, Japan, Takeda ) and Pronova BioPharma ASA (Lysaker, Norway, Pronova ) today jointly announced the top-line resul” View full resource at drugs.com
Most Recently Shared on May 10, 2011 at 2:12 pm By:
Top-line Results of the Pivotal Phase 3 Clinical Trial of TAK-085 in Japan for Treatment of Hypertriglycer... http://bit.ly/iUwxG7 #drug
Triglycerides on #MDlinx
mdlinx.com — “Triglycerides on #MDlinx” View full resource at mdlinx.com
Most Recently Shared on October 2, 2010 at 2:02 am By:
Durability of Effects of Exenatide Treatment on Glycemic Control, Body Weight, Systolic Blood Pressure, C... http://bit.ly/9H9elu #diabetes
Essentialis To Submit SPA For Hypertriglyceridemia
medicalnewstoday.com — “Essentialis, inc., a clinical stage pharmaceutical company, announced today its intention to file a special protocol assessment (spa) with the fda for the pivotal study to support the nda filing o” View full resource at medicalnewstoday.com
Most Recently Shared on August 13, 2009 at 11:20 am By:
MedicalNewsToday: Essentialis To Submit SPA For Hypertriglyceridemia http://bit.ly/2hLqoG Full http://bit.ly/PXudk
Triglycerides - huh? - TuDiabetes
tudiabetes.org — “Just when I think I am getting a handle on all of this, another monkey pitchesanother wrench at me. What are triglycerides and why do I need to know? If my blood sugar is within or close to limits, do I need to worry about triglycerides? If my triglycerides are not where they should be, how would I know? Is this another test I need to get done? Can a treatment regime, drugs and diet and exercise, that is good for blood sugar levels be bad for triglycerides? I have heard that in some people certa” View full resource at tudiabetes.org
Most Recently Shared on June 30, 2010 at 3:47 pm By:
Type 2 #diabetes: Triglycerides - huh?: Just when I think I am getting a handle on all of this, another monkey pit... http://bit.ly/am8qzL
Phase 3 study of AMR101 for the treatment of high triglycerides - MPR
empr.com — “Amarin Corporation announced the enrollment of patients in their two Phase 3 trials of AMR101 for the treatment of patients with high triglycerides.” View full resource at empr.com
Most Recently Shared on January 11, 2010 at 5:01 pm By:
MPR News: Phase 3 study of AMR101 for the treatment of high triglycerides: Amarin Corporation announced the enroll... http://bit.ly/4Fss8g
High blood cholesterol and triglycerides - Lenox Hill Hospital
lenoxhillhospital.org — “High blood cholesterol and triglycerides - Lenox Hill Hospital” View full resource at lenoxhillhospital.org
Most Recently Shared on September 16, 2010 at 7:00 pm By:
It's National Cholesterol Education Month. To learn about causes, prevention and treatment for high cholesterol visit: http://cot.ag/d94NX6
Phase 3 Trial of Epanova for Hypertriglyceridemia - ONA
oncologynurseadvisor.com — “Omthera Pharmaceuticals announced the initiation of its Phase 3 EVOLVE (EpanoVa fOr Lowering Very high triglyceridEs) trial evaluating Epanova for the treatment of patients with very high triglycerides.” View full resource at oncologynurseadvisor.com
Most Recently Shared on March 14, 2011 at 3:14 pm By:
Phase 3 Trial of Epanova for Hypertriglyceridemia http://goo.gl/fb/R4B5D
Phase 3 Trial of Epanova for Hypertriglyceridemia - MPR
empr.com — “Omthera Pharmaceuticals announced the initiation of its Phase 3 EVOLVE (EpanoVa fOr Lowering Very high triglyceridEs) trial evaluating Epanova for the treatment of patients with very high triglycerides.” View full resource at empr.com
Most Recently Shared on March 14, 2011 at 3:48 pm By:
MPR News: Phase 3 Trial of Epanova for Hypertriglyceridemia: Omthera Pharmaceuticals announced the initiation of... http://bit.ly/i4FZ5e
Phase 3 Study of AMR101 for Hypertriglyceridemia - ONA
oncologynurseadvisor.com — “Amarin Corporation announced positive results from its Phase 3 study of AMR101 for the treatment of patients with high triglycerides (TG) without increasing LDL-C levels in patients on background statin therapy.” View full resource at oncologynurseadvisor.com
Most Recently Shared on April 18, 2011 at 2:34 pm By:
Phase 3 Study of AMR101 for Hypertriglyceridemia http://goo.gl/fb/8o86e
Phase 3 Study of AMR101 for Hypertriglyceridemia - MPR
empr.com — “Amarin Corporation announced positive results from its Phase 3 study of AMR101 for the treatment of patients with high triglycerides (TG) without increasing LDL-C levels in patients on background statin therapy.” View full resource at empr.com
Most Recently Shared on April 18, 2011 at 3:06 pm By:
MPR News: Phase 3 Study of AMR101 for Hypertriglyceridemia: Amarin Corporation announced positive results from i... http://bit.ly/dIGbsJ
Gastroenterology Article | Incidence of pancreatitis, secondary causes, and treatment of patients referred to a specialty lipid clinic with severe hypertriglyceridemia: A retrospective cohort study
mdlinx.com — “Incidence of pancreatitis, secondary causes, and treatment of patients referred to a specialty lipid clinic with severe hypertriglyceridemia: A retrospective cohort study” View full resource at mdlinx.com
Most Recently Shared on September 22, 2011 at 8:07 am By:
Incidence of pancreatitis, secondary causes, and treatment of patients referred to a specialty lipid clinic ... http://t.co/JlBgD5ao #GI
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Related WisdomCards
Featuring the top 3 experts for this topic
-
OncologyNurseAdvisor
Oncology Nurse Advisor offers clinical updates and evidence-based guidance to the oncology nurse community and includes regular coverage of a variety of topics.
-
OncologyNurseAdvisor
Oncology Nurse Advisor offers clinical updates and evidence-based guidance to the oncology nurse community and includes regular coverage of a variety of topics.
-
MPR
eMPR.com provides up-to-date, concise drug information at the point-of-care.
Advertisement

